Home

Influx Healthtech PE Ratio

Image

Influx Healthtech Ltd

NSE: InfluxHealth.

PE

26.9

Last updated on: Jul 15, 2025

Key Highlights

  • The P/E Ratio of Influx Healthtech Ltd is 26.9 as of 15 Jul 25 .
  • The P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Influx Healthtech Ltd is ₹ 155.35 as of 15 Jul 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 16.9. The PE Ratio of Finance industry is 27.8. The PE Ratio of IT - Software industry is 27.0. The PE Ratio of Pharmaceuticals industry is 30.9. The PE Ratio of Retail industry is 109.6. The PE Ratio of Textiles industry is 22.5 in 2025.

Historical P/E Ratio of Influx Healthtech Ltd

No data available

Company Fundamentals for Influx Healthtech Ltd

Image

Influx Healthtech Ltd

NSE: InfluxHealth.

Share Price

₹ 155.35

-12.25 (-7.31%)

stock direction

Last updated on: Jul 15, 2025

Market Price of Influx Healthtech Ltd

1M

1Y

3Y

5Y

Monitoring Influx Healthtech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jul 2025155.35
14 Jul 2025167.6
11 Jul 2025179.05
10 Jul 2025166.3
09 Jul 2025168.75
08 Jul 2025144.75
07 Jul 2025137.9
04 Jul 2025131.35
03 Jul 2025125.1
02 Jul 2025124.15

BlinkX Score for Influx Healthtech Ltd

Asset Value vs Market Value of Influx Healthtech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Influx Healthtech Ltd Explained

359.64

Market cap

13

Earnings

26.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Influx Healthtech Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Influx Healthtech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Influx Healthtech Ltd

No data available

* All values are in %

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Influx Healthtech Ltd News Hub

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public offer (IPO)

Read more

25 Jun 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions